Cost-effectiveness of apixaban, dabigatran, rivaroxaban, and warfarin for stroke prevention in atrial fibrillation (Q86524071)
Jump to navigation
Jump to search
scientific article published on 02 April 2013
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Cost-effectiveness of apixaban, dabigatran, rivaroxaban, and warfarin for stroke prevention in atrial fibrillation |
scientific article published on 02 April 2013 |
Statements
Cost-effectiveness of apixaban, dabigatran, rivaroxaban, and warfarin for stroke prevention in atrial fibrillation (English)
Amanda R Harrington
Edward P Armstrong
Paul E Nolan
Daniel C Malone